drugset / Trial / NCT04285320

Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract Infections

NCT04285320

Phase 4 Unknown 100 enrolled Atlantic Health System
RandomizedParallel-groupOpen-labelPrevention

Summary

This is a research study that aims to determine if antibiotic bladder instillations (placing an antibiotic directly into the bladder) over several sessions at the office is a good option to prevent recurrent urinary tract infections, in comparison with oral suppression therapy (taking daily antibiotics in the form of pills by mouth). Oral antibiotic suppression therapy is currently the most common treatment route for recurrent urinary tract infections in post-menopausal women. The bladder antibiotic instillation may overcome the disadvantages of oral suppression therapy such as antibiotic resistance, certain side effects, and recurrence of infections after finishing the treatment course.

Timeline

Start
2021-03
Primary completion
2023-04
Completion
2023-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amikacin Small molecule 30 mg Intravenous
Comparator CEPHALEXIN ANHYDROUS Small molecule 125 mg Oral
Comparator CEPHALEXIN ANHYDROUS Small molecule 250 mg Oral
Comparator Fosfomycin Small molecule 3 g Oral
Comparator Gentamicin Small molecule 80 mg Intravenous
Comparator Nitrofurantoin Unknown 50 mg Oral
Comparator Nitrofurantoin Unknown 100 mg Oral
Comparator Tobramycin Small molecule 80 mg Intravenous
Comparator Trimethoprim Small molecule 100 mg Oral
Comparator Trimethoprim/sulfamethoxazole Unknown 40 mg Oral
Comparator Trimethoprim/sulfamethoxazole Unknown 200 mg Oral